Sevenfact® (coagulation factor VIIa [recombinant]-jncw)

Sevenfact is covered only for IV treatment, control, or prevention of bleeding episodes in patients ≥12 years with hemophilia A or B with inhibitors (not covered for <12 or other indications), with authorization up to 12 months. Approval requires documentation of diagnosis, patient age, treatment intent, a hematologist/hemophilia specialist prescription or consult, and use consistent with the policy’s dosing regimens (specified 75 mcg/kg and 225 mcg/kg schedules for mild/moderate and severe bleeds).

"Approval duration limited to 12 months."

Sign up to see full coverage criteria, indications, and limitations.